Capillary Electrophoresis Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 408.05 Million
CAGR (2026-2031)	5.92%
Fastest Growing Segment	Instruments
Largest Market	North America
Market Size (2031)	USD 576.21 Million

Market Overview

The Global Capillary Electrophoresis Market will grow from USD 408.05 Million in 2025 to USD 576.21 Million by 2031 at a 5.92% CAGR. Capillary Electrophoresis is an analytical technique that separates ions based on their electrophoretic mobility with the use of an applied voltage within a submillimeter diameter capillary tube. The market is primarily propelled by the rising prevalence of chronic diseases and the subsequent demand for personalized medicine, which necessitates precise diagnostic tools for biomarker identification. Furthermore, the expanding biopharmaceutical industry relies heavily on this technology for the detailed characterization of monoclonal antibodies and quality control during drug production. These fundamental drivers are distinct from technological trends such as miniaturization or the integration of mass spectrometry, as they represent the core demands fueling adoption rather than the evolution of the method itself.

Despite the positive trajectory, the market faces a significant impediment regarding the shortage of skilled professionals capable of operating these complex systems and interpreting the resulting data. This lack of expertise can bottleneck laboratory throughput and delay the adoption of advanced methodologies. To illustrate the industrial scale of the sector supporting these technologies, data from major trade organizations provides insight into manufacturing output. According to the Japan Analytical Instruments Manufacturers' Association, in 2024, the production value of separation analysis apparatus, a category essential to the capillary electrophoresis market, reached approximately 64.8 billion JPY.

Key Market Drivers

Rising pharmaceutical and biotechnology R&D expenditure is a primary engine driving the global capillary electrophoresis market. As the industry increasingly focuses on complex biologics, such as monoclonal antibodies and gene therapies, the demand for high-resolution analytical techniques to ensure drug purity and stability has surged. Capillary electrophoresis is indispensable for characterizing charge heterogeneity and glycan analysis during these expanded development phases, prompting significant investment in the necessary instrumentation. This intensification of research activity is evidenced by the financial commitments of leading industry players. According to Johnson & Johnson, in January 2025, the company reported research and development expenses of $17.2 billion for the full year 2024, reflecting the substantial capital allocation fueling the adoption of advanced analytical tools for drug discovery and development.

Technological advancements, particularly the emergence of microchip-based capillary electrophoresis, are further accelerating market growth by addressing historical limitations in throughput and sensitivity. These innovations allow for faster separation times and seamless integration with mass spectrometry, which is critical for modern genomics and proteomics research. The enhanced performance of these miniaturized systems is enabling more precise biomarker identification. For instance, according to the Journal of Chromatography A, January 2025, in the article 'Microchip capillary electrophoresis-mass spectrometry for high-throughput simultaneous analysis of B-complex vitamins', a newly developed microchip-based method demonstrated limits of detection lower than 4 ppb while achieving separation times of under three minutes. To illustrate the broader industrial context supporting these technologies, according to Bio-Rad Laboratories, in 2025, the company reported full-year 2024 net sales of $1.03 billion for its Life Science segment, highlighting the significant market scale for research and clinical diagnostic instrumentation.

Download Free Sample Report

Key Market Challenges

The shortage of skilled professionals presents a critical barrier to the expansion of the Global Capillary Electrophoresis Market. Unlike simpler analytical methods, capillary electrophoresis requires operators with specific technical expertise to manage method development, buffer selection, and the interpretation of intricate data sets. When laboratories lack personnel with this requisite proficiency, they experience operational bottlenecks that reduce sample throughput and increase the risk of analytical errors. This human resource gap directly disincentivizes organizations from investing in new instrumentation, as the hardware cannot be utilized to its full capacity without competent oversight, thereby stalling capital equipment procurement.

The impact of this workforce scarcity is amplified by the substantial volume of technical systems being distributed globally, which creates a demand for expertise that the current labor pool cannot meet. As manufacturers supply these complex instruments to international markets, the local need for trained operators intensifies. Illustrating this global distribution, according to the Japan Analytical Instruments Manufacturers' Association, in 2024, the export value of separation analysis apparatus was approximately 37.3 billion JPY. This significant outflow of technology highlights a widening disparity between the availability of advanced diagnostic tools and the number of qualified experts available to operate them, effectively limiting the market's practical growth rate.

Key Market Trends

The expansion into plasmid DNA and viral vector analysis for gene therapies represents a critical evolution in the capillary electrophoresis market, distinct from traditional protein characterization. As the biopharmaceutical sector accelerates the production of cell and gene therapies, manufacturers increasingly rely on capillary electrophoresis for the precise separation of supercoiled plasmid DNA from linear isoforms and the determination of empty versus full viral capsids. This specific application is vital for ensuring the safety and efficacy of complex genetic medicines, driving the installation of advanced analytical infrastructure. The scale of investment in the instrumentation supporting these sophisticated workflows is substantial. According to Thermo Fisher Scientific, January 2025, in the 'Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results' press release, the company’s Analytical Instruments segment, which enables the development and manufacture of these life-changing therapies, generated revenue of $2.19 billion for the fourth quarter of 2024 alone.

Concurrently, the market is undergoing a decisive shift towards fully automated, high-throughput capillary electrophoresis workflows to address laboratory efficiency and reproducibility. Laboratories are moving away from manual gel-based methods and single-capillary systems in favor of parallel processing platforms that can analyze multiple samples simultaneously with minimal operator intervention. This trend is fueled by the need to streamline quality control processes and generate rapid, digital data for large-scale screening applications, effectively mitigating human error and operational bottlenecks. The robust demand for such automated measurement solutions is reflected in the financial performance of key equipment providers. According to Shimadzu Corporation, February 2025, in the 'Earnings Report for the nine months ended December 31, 2024', the Analytical & Measuring Instruments segment achieved net sales of approximately 247.9 billion JPY, highlighting the continued industrial reliance on advanced, high-efficiency separation technologies.

Segmental Insights

The Instruments segment is emerging as the fastest-growing category in the Global Capillary Electrophoresis Market, driven by the increasing adoption of automated systems for pharmaceutical quality control. Laboratories are prioritizing upgrades to advanced platforms that ensure compliance with rigorous testing standards established by agencies such as the U.S. Food and Drug Administration. This growth is further propelled by technological improvements in microfluidics, which enable higher throughput and precision in drug discovery processes. As biotechnology companies seek to streamline their analytical workflows, the demand for modern, integrated electrophoresis instruments continues to outpace other market segments.

Regional Insights

North America maintains a leading position in the global capillary electrophoresis market, driven by a well-established pharmaceutical and biotechnology sector. The region benefits from substantial investments in genomic research and drug development. A key factor supporting this dominance is the rigorous regulatory environment enforced by the US Food and Drug Administration, which necessitates precise analytical methods for product safety and quality control. Consequently, laboratories and research facilities frequently utilize capillary electrophoresis to meet these compliance standards. Furthermore, strong collaboration between academic institutions and industry players accelerates the adoption of this technology across the region.

Recent Developments

In March 2025, Thermo Fisher Scientific launched the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, an advanced capillary electrophoresis system compliant with In Vitro Diagnostic Regulation (IVDR). Designed to meet the rigorous demands of clinical and hospital laboratories, the system supports Sanger sequencing and fragment analysis for targeted genomic testing. It features three operating modes—IVD, Investigational Use Only, and Research Use Only—enabling flexible workflows on a single platform. The instrument was engineered to improve diagnostic efficiency and adhere to stringent regulatory standards, offering features such as continuous plate loading and smart connectivity to streamline laboratory operations.
In April 2024, Sebia announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CAPILLARYS 3 DBS devices. This instrument utilizes capillary electrophoresis technology for the qualitative detection of normal and abnormal hemoglobins in dried blood spot samples collected from newborns. The regulatory clearance allowed the company to expand its portfolio in the United States, offering laboratories a solution that enhances operational efficiency through high throughput and full traceability. The system automates the analysis process, significantly reducing manual intervention and ensuring accurate decision-making support for hemoglobin disorder screening in clinical settings.
In February 2024, Sysmex Corporation and Hitachi High-Tech Corporation entered into a strategic collaborative agreement to develop new genetic testing systems utilizing capillary electrophoresis sequencer technology. This partnership aimed to create more efficient and cost-effective testing solutions to expand access to genetic testing for individual diseases globally. By combining Sysmex’s global sales network and diagnostic content development capabilities with Hitachi High-Tech’s extensive expertise in designing high-performance capillary electrophoresis instruments, the companies sought to accelerate the adoption of these advanced diagnostic tools. The collaboration focused on delivering high-value testing environments to healthcare providers and clinical laboratories worldwide.
In January 2024, Agilent Technologies Inc. announced the release of the ProteoAnalyzer system, an automated parallel capillary electrophoresis platform specifically designed for protein analysis. This new system was introduced to simplify and enhance the efficiency of analyzing complex protein mixtures, a workflow that is essential across pharmaceutical, biotechnology, and academic sectors. The platform allows for the analysis of various protein sizes and types in a single run, delivering accurate and consistent results. This launch addressed the growing demand for capillary electrophoresis solutions, which is being driven by the biopharmaceutical industry's expanding interest in monoclonal antibodies and therapeutic protein targets.

Key Market Players

QIAGEN N.V.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
PerkinElmer, Inc
Merck KGaA
Promega Corporation
Shimadzu Corporation
LABGENE Scientific SA

By Component	By Mode	By Application	By End User	By Region
Instruments Consumables Software	Capillary Zone Electrophoresis Capillary Electro Chromatography Others	Nucleic Acid Analysis and Protein Analysis	Biotechnology & Pharmaceutical Companies Clinical Laboratories Academic & Research Institutions Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Capillary Electrophoresis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Electrophoresis Market, By Component:

Instruments
Consumables
Software

Capillary Electrophoresis Market, By Mode:

Capillary Zone Electrophoresis
Capillary Electro Chromatography
Others

Capillary Electrophoresis Market, By Application:

Nucleic Acid Analysis and Protein Analysis

Capillary Electrophoresis Market, By End User:

Biotechnology & Pharmaceutical Companies
Clinical Laboratories
Academic & Research Institutions
Others

Capillary Electrophoresis Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Electrophoresis Market.

Available Customizations:

Global Capillary Electrophoresis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Capillary Electrophoresis Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Electrophoresis Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Component (Instruments, Consumables, Software)

5.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)

5.2.3. By Application (Nucleic Acid Analysis and Protein Analysis)

5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)

5.2.5. By Region

5.2.6. By Company (2025)

5.3. Market Map

6. North America Capillary Electrophoresis Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Component

6.2.2. By Mode

6.2.3. By Application

6.2.4. By End User

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Capillary Electrophoresis Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Component

6.3.1.2.2. By Mode

6.3.1.2.3. By Application

6.3.1.2.4. By End User

6.3.2. Canada Capillary Electrophoresis Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Component

6.3.2.2.2. By Mode

6.3.2.2.3. By Application

6.3.2.2.4. By End User

6.3.3. Mexico Capillary Electrophoresis Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Component

6.3.3.2.2. By Mode

6.3.3.2.3. By Application

6.3.3.2.4. By End User

7. Europe Capillary Electrophoresis Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Component

7.2.2. By Mode

7.2.3. By Application

7.2.4. By End User

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Capillary Electrophoresis Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Component

7.3.1.2.2. By Mode

7.3.1.2.3. By Application

7.3.1.2.4. By End User

7.3.2. France Capillary Electrophoresis Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Component

7.3.2.2.2. By Mode

7.3.2.2.3. By Application

7.3.2.2.4. By End User

7.3.3. United Kingdom Capillary Electrophoresis Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Component

7.3.3.2.2. By Mode

7.3.3.2.3. By Application

7.3.3.2.4. By End User

7.3.4. Italy Capillary Electrophoresis Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Component

7.3.4.2.2. By Mode

7.3.4.2.3. By Application

7.3.4.2.4. By End User

7.3.5. Spain Capillary Electrophoresis Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Component

7.3.5.2.2. By Mode

7.3.5.2.3. By Application

7.3.5.2.4. By End User

8. Asia Pacific Capillary Electrophoresis Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Component

8.2.2. By Mode

8.2.3. By Application

8.2.4. By End User

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Capillary Electrophoresis Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Component

8.3.1.2.2. By Mode

8.3.1.2.3. By Application

8.3.1.2.4. By End User

8.3.2. India Capillary Electrophoresis Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Component

8.3.2.2.2. By Mode

8.3.2.2.3. By Application

8.3.2.2.4. By End User

8.3.3. Japan Capillary Electrophoresis Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Component

8.3.3.2.2. By Mode

8.3.3.2.3. By Application

8.3.3.2.4. By End User

8.3.4. South Korea Capillary Electrophoresis Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Component

8.3.4.2.2. By Mode

8.3.4.2.3. By Application

8.3.4.2.4. By End User

8.3.5. Australia Capillary Electrophoresis Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Component

8.3.5.2.2. By Mode

8.3.5.2.3. By Application

8.3.5.2.4. By End User

9. Middle East & Africa Capillary Electrophoresis Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Component

9.2.2. By Mode

9.2.3. By Application

9.2.4. By End User

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Capillary Electrophoresis Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Component

9.3.1.2.2. By Mode

9.3.1.2.3. By Application

9.3.1.2.4. By End User

9.3.2. UAE Capillary Electrophoresis Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Component

9.3.2.2.2. By Mode

9.3.2.2.3. By Application

9.3.2.2.4. By End User

9.3.3. South Africa Capillary Electrophoresis Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Component

9.3.3.2.2. By Mode

9.3.3.2.3. By Application

9.3.3.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Component

10.2.2. By Mode

10.2.3. By Application

10.2.4. By End User

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Capillary Electrophoresis Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Component

10.3.1.2.2. By Mode

10.3.1.2.3. By Application

10.3.1.2.4. By End User

10.3.2. Colombia Capillary Electrophoresis Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Component

10.3.2.2.2. By Mode

10.3.2.2.3. By Application

10.3.2.2.4. By End User

10.3.3. Argentina Capillary Electrophoresis Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Component

10.3.3.2.2. By Mode

10.3.3.2.3. By Application

10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Capillary Electrophoresis Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. QIAGEN N.V.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Thermo Fisher Scientific Inc.

15.3. Agilent Technologies, Inc.

15.4. Bio-Rad Laboratories, Inc.

15.5. Danaher Corporation

15.6. PerkinElmer, Inc

15.7. Merck KGaA

15.8. Promega Corporation

15.9. Shimadzu Corporation

15.10. LABGENE Scientific SA

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Capillary Electrophoresis Market in 2025?

Which is the dominating region in the Global Capillary Electrophoresis Market?

Which is the fastest growing segment in the Global Capillary Electrophoresis Market?

What is the expected growth rate of the Global Capillary Electrophoresis Market?